NeuroSense Therapeutics Ltd

NeuroSense Therapeutics is advancing ALS and neurodegenerative disease therapies, trading on Nasdaq with volatile stock prices, yet focused on breakthrough treatments.

NeuroSense Therapeutics Ltd is a clinical-stage company pioneering innovative treatments for neurodegenerative diseases, such as ALS, with a global operational footprint and a promising future outlook.

NeuroSense Therapeutics Ltd is a clinical-stage drug development company pioneering innovative treatments for neurodegenerative diseases, including ALS, with a global operational footprint and commitment to accessibility.